CLEARLINK CONTINU-FLO SOLUTION SET
Report
- Report Number
- 1416980-2021-00436
- Event Type
- Malfunction
- Date Received
- February 5, 2021
- Date of Event
- December 28, 2020
- Report Date
- March 12, 2021
- Manufacturer
- BAXTER HEALTHCARE CORPORATION
- Product Code
- FPA
- PMA / PMN Number
- K961225
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- CA
- Reporter Occupation
- OTHER
Narratives
ADDITIONAL INFORMATION WAS ADDED TO B5, D9, D4, G1, G4, H3 AND H6 B5. THE AFFECTED PRODUCT IS ¿CLEARLINK SYSTEM CONTINU-FLO SOLUTION SET¿, PREVIOUSLY SUBMITTED AS ¿UNSPECIFIED BAXTER SET¿. D1: THE BRAND NAME OF THE AFFECTED PRODUCT IS ¿CLEARLINK CONTINU-FLO SOLUTION SET¿, PREVIOUSLY SUBMITTED AS ¿NI¿. D4: CATALOGUE #: 2C8537, PREVIOUSLY SUBMITTED AS ¿ASKU¿. G1. DEVICE MANUFACTURER ADDRESS: ¿SEE H10¿, PREVIOUSLY SUBMITTED AS ¿NI¿. G1: DEVICE MANUFACTURER STATE: ¿NA¿, PREVIOUSLY SUBMITTED AS ¿NI¿. G4: PMA/510K # OR BLA #: ¿K961225¿, PREVIOUSLY SUBMITTED AS ¿NI¿. G1: MANUFACTURING FACILITY-THIS DEVICE WAS MANUFACTURED AT ONE OF THE TWO FOLLOWING MANUFACTURING SITES: BAXTER HEALTHCARE - CARTAGO 600 MTS. OESTE DE ENTRADA, PRINCIPAL AVE. LAS AMERICAS, PARQUE INDUSTRIAL CARTAGO COSTA RICA 30106 OR BAXTER HEALTHCARE - DOMINICAN REPUBLIC: CARRETERA SANCHEZ KM 18.5 PARQUE INDUSTRIAL ITABO, PIISA HAINA SAN CRISTOBAL DOMINICAN REPUBLIC. H10: THE DEVICE WAS RECEIVED FOR EVALUATION. VISUAL INSPECTION WAS PERFORMED USING THE NAKED EYE DID NOT IDENTIFY ANY ABNORMALITIES THAT COULD HAVE CONTRIBUTED TO THE REPORTED CONDITION. FUNCTIONAL TESTING WAS PERFORMED INCLUDING CLEAR PASSAGE AND PRESSURE TESTING; AND THE DEVICE PERFORMED ACCORDING TO PRODUCT SPECIFICATIONS. NO FLOW WAS NOT OBSERVED IN THE SAMPLE. THE REPORTED CONDITION WAS NOT VERIFIED. SHOULD ADDITIONAL RELEVANT INFORMATION BECOME AVAILABLE, A SUPPLEMENTAL REPORT WILL BE SUBMITTED.
SHOULD ADDITIONAL RELEVANT INFORMATION BECOME AVAILABLE, A SUPPLEMENTAL REPORT WILL BE SUBMITTED.
IT WAS REPORTED THAT AN UNSPECIFIED BAXTER SET WOULD NOT FLOW WHILE IN USE WITH A SPECTRUM IQ PUMP. IT WAS FURTHER REPORTED THAT THE HEPARIN WAS INFUSING HOWEVER THERE WERE NO DROPS IN THE DRIP CHAMBER. THIS ISSUE WAS IDENTIFIED DURING PATIENT INFUSION. THERE WAS NO PATIENT INJURY OR MEDICAL INTERVENTION ASSOCIATED WITH THIS EVENT. NO ADDITIONAL INFORMATION IS AVAILABLE.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 183974 | CLEARLINK CONTINU-FLO SOLUTION SET | SET, ADMINISTRATION, INTRAVASCULAR | FPA | BAXTER HEALTHCARE CORPORATION | NA | ASKU |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | HEPARIN| SPECTRUM IQ PUMP |